AZN
AstraZeneca PLC
Stock
$156.90−0.80 (−0.51%)Close Oct 2, 2026
- Capital expenditures, 2025
- $2.8B
- YoY, 2025
- +46.0%
- 5-year CAGR
- +23.9%
- 10-year CAGR
- +7.8%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $2.8B | +46.0% |
| 2024 | $1.9B | +41.4% |
| 2023 | $1.4B | +24.7% |
| 2022 | $1.1B | 0.0% |
| 2021 | $1.1B | +13.5% |
| 2020 | $961M | −1.8% |
| 2019 | $979M | −6.1% |
| 2018 | $1.0B | −21.3% |
| 2017 | $1.3B | −8.3% |
| 2016 | $1.4B | +8.9% |
| 2015 | $1.3B | — |